RVX-297
RVX-297 is a potent, orally active BET bromodomain inhibitor with selectivity for BD2. RVX-297 shows IC50s of 0.08, 0.05, and 0.02 μM for BRD2 (BD2), BRD3 (BD2), and BRD4 (BD2), respectively. RVX-297 suppresses inflammatory gene expression in multiple immune cell types. RVX-297 is effective in acute inflammation and autoimmunity models[1][2].
Product Specifications
CAS Number
1044871-04-6
UNSPSC
12352005
Hazard Statement
H302, H312, H332
Target
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Applications
COVID-19-anti-virus
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/rvx-297.html
Purity
95.00
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C1NC(C2=CC(C)=C(OCCN3CCCC3)C(C)=C2)=NC4=C1C(OC)=CC(OC)=C4
Molecular Formula
C24H29N3O4
Molecular Weight
423.50
Precautions
H302, H312, H332
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
BRD2; BRD3; BRD4; BRDT
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
